O-195 Activating mutations (muts) in the tyrosine kinase (TK)domain of the epidermal growth factor receptor (EGFR) and of the platelet-derived growth factor receptor α (PDGFRA) in gefitinib-treated non-small-cell lung cancer (NSCLC) patients | Publicación